QUANTUM-SI INCORPORATED (QSI) Spending and interest coverage
- R&D / revenue · 12 months: Value 3435.51%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 693.46%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3435.51% | Research and development expense / revenue. Period ending 2026-06-30. $55.14M ÷ $1.60M × 100 ≈ 3435.51% |
| Stock-based compensation / revenue · 12 months | 693.46% | Share-based compensation / revenue. Period ending 2026-06-30. $11.13M ÷ $1.60M × 100 ≈ 693.46% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 55.14M USD | Research and Development Expense |
| Revenue | 1.60M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 11.13M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -110.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $55.14M | $1.60M | $11.13M | $-110.55M | (m) | 3435.51% | 693.46% | (m) | (m) |
| 2026-03-31 | $54.53M | $1.85M | $10.98M | $-115.04M | (m) | 2944.33% | 592.66% | (m) | (m) |
| 2025-12-31 | $53.76M | $2.44M | $10.77M | $-116.10M | (m) | 2206.86% | 442.24% | (m) | (m) |
| 2025-09-30 | $59.80M | $3.18M | $10.49M | $-125.68M | (m) | 1882.31% | 330.19% | (m) | (m) |
| 2025-06-30 | $62.09M | $3.41M | $10.07M | $-114.00M | (m) | 1819.72% | 295.25% | (m) | (m) |
| 2025-03-31 | $61.26M | $3.44M | $9.60M | $-110.33M | (m) | 1779.18% | 278.94% | (m) | (m) |
| 2024-12-31 | $59.64M | $3.06M | $8.89M | $-108.58M | (m) | 1950.33% | 290.61% | (m) | (m) |
| 2024-09-30 | $59.09M | $2.27M | $8.08M | $-105.78M | (m) | 2607.68% | 356.75% | (m) | (m) |
| 2024-06-30 | $59.51M | $1.70M | $6.81M | $-104.87M | (m) | 3496.24% | 400.35% | (m) | (m) |
| 2024-03-31 | $60.96M | $1.28M | $6.25M | $-105.31M | (m) | 4743.89% | 486.61% | (m) | (m) |
| 2023-12-31 | $67.03M | $1.08M | $8.52M | $-111.17M | (m) | 6194.55% | 787.06% | (m) | (m) |
| 2023-09-30 | $68.75M | (m) | $11.02M | $-122.13M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $68.83M | (m) | $13.92M | $-122.61M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $71.46M | (m) | $15.83M | $-125.92M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $72.06M | (m) | $11.21M | $-123.84M | $0.00 | (m) | (m) | (m) | Reported |
| 2022-09-30 | $68.29M | (m) | $14.18M | $-112.79M | $0.00 | (m) | (m) | (m) | Reported |
| 2022-06-30 | $62.72M | (m) | $17.53M | $-110.31M | $0.00 | (m) | (m) | (m) | Reported |
| 2022-03-31 | $57.37M | (m) | $23.75M | $-112.27M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $46.58M | (m) | $24.92M | $-96.91M | $5.00K | (m) | (m) | -19381.60× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $28.10M | (m) | $2.71M | $-36.62M | $0.00 | (m) | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.